Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

The X Factor at SXSW

Three healthcare advertising agencies came together at South By Southwest to create a wide new range of possibilities for the ever-growing Health and MedTech Track.

Read More »

Longer night fasting tied to reduced breast cancer recurrence

For breast cancer survivors, the risk of recurrence may be tied to how many hours they fast at night, a new study suggests.

Read More »

Longer night fasting tied to reduced breast cancer recurrence

<span class="articleLocation”>(Reuters Health) – For breast cancer survivors, the risk of recurrence may be tied to how many hours they fast at night, a new study suggests. Women in the study were more likely to have their breast cancer come back if they fasted overnight for less than 13 hours, researchers found. While prolonged fasting […]

Read More »

U.S. FTC sues Endo alleging antitrust violations

The U.S. Federal Trade Commission said it filed a complaint in a district court accusing Endo International Plc of violating antitrust laws by striking “pay-for-delay” deals.

Read More »

Takeda Launches Multi-Year Research Partnership for IBD

Takeda Pharmaceuticals U.S.A. announced a multi-year research partnership with two world-leading academic centers with a proven long-term commitment to IBD research and care.

Read More »

GlaxoSmithKline promises reduced drug patents to help world’s poor

GlaxoSmithKline is to adopt a graduated approach to patenting its medicines, depending on the wealth of different countries, in order to make drugs more affordable in the developing world.   Britain’s biggest drugmaker said on Thursday it would not file patents in low-income states, leaving the way clear for generic companies to make cheap copies […]

Read More »

Baricitinib Results in Significant Improvements for Certain RA Patients

Phase 3 Study Findings Demonstrate Treatment with Baricitinib Results in Significant Improvements for Patients with Rheumatoid Arthritis Who Had Inadequate Response to Biologics Pivotal RA-BEACON Study Published in New England Journal of Medicine 07:00 ET from Eli Lilly and Company; Incyte Corporation   INDIANAPOLIS, March 31, 2016 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) […]

Read More »

1,000+ Women Suing Johnson & Johnson for Alleged Cover Up

1,000+ Women are Suing Johnson & Johnson for Allegedly Covering Up Baby Powder Cancer Risk for Decades     March 31, 2016By Alex Keown, BioSpace.com Breaking News Staff   WASHINGTON – More than 1,000 women have joined a lawsuit against Johnson & Johnson (JNJ) claiming the company failed to provide information about risks of ovarian […]

Read More »

Jazz Pharmaceuticals Announces FDA Approval of Defitelio for Hepatic VOD

Jazz Pharmaceuticals Announces FDA Approval of Defitelio (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease (VOD) with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation (HSCT)   First and Only FDA-Approved Therapy for Patients with this Rare, Potentially Fatal Complication     DUBLIN, March 30, 2016 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that […]

Read More »

FDA permits use of Roche test to screen donated blood for Zika

The U.S. Food and Drug Administration said it would allow the use of an experimental test to screen donated blood for the Zika virus.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2018 Focus: Top 50 Pharma, Company of the Year and more!

Subscribe

Ad Right Bottom